Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Galapagos NV

www.glpg.com

Latest From Galapagos NV

The Only Way Is Nasdaq – Part One

The US Nasdaq exchange has become the only option for ambitious UK and European biotechs.

Business Strategies C-Suite Speaks

Gilead Writes Down Kite Buy As Yescarta Sales Flatten Out

Gilead takes $800m impairment charge against Kite acquisition a year after an $820m write-down. Kite and Yescarta are appear to be afterthoughts in discussions of Gilead’s portfolio and pipeline.

Sales & Earnings Business Strategies

2019’s Top Biopharma Deal-Makers

Gene therapy and targeted oncology treatments dominated the biggest acquisitions of the year. Boehringer Ingelheim and Roche were the most active big pharma in-licensers. Cancer and neurology were the focus of most alliances and financings.

Deals Market Intelligence

Deal Watch: Novo Nordisk, Fauna To Explore Hibernation To Treat Obesity

A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.

Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Galapagos Genomics NV
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Belgium
  • Parent & Subsidiaries
  • Galapagos NV
  • Senior Management
  • Onno van de Stolpe, CEO
    Bart Filius, CFO & COO
    Andre Hoekema, PhD, CBO
    Piet Wigerinck, PhD, CSO
    Walid Abi-Saab, MD, CMO
    Michele Manto, Chief Commercial Officer
  • Contact Info
  • Galapagos NV
    Phone: (32) 15 34 29 00
    Generaal De Wittelaan L11 A3
    Mechelen, 2800
    Belgium
UsernamePublicRestriction

Register